期刊文献+

超声造影剂量对肾恶性肿瘤时间-强度曲线参数影响

Effect on time-intensity curve parameters with different doses of ultrasound contrast agent in renal malignant tumors
下载PDF
导出
摘要 目的探讨超声造影剂量对肾恶性肿瘤造影时间-强度曲线参数的影响。方法将31例肾恶性肿瘤患者按剂量1.2、1.5、2.0、2.4 ml分为4组进行超声造影检查,应用时间-强度曲线获得4组定量参数,包括始增时间、达峰时间、峰值强度、曲线上升支斜率、曲线上升支下面积,分析4组参数与造影剂剂量的关系。结果始增时间、达峰时间均随剂量增加而缩短,2.4 ml组与其他3组间差异有统计学意义(P<0.05);峰值强度随造影剂量增加而增强,2.4 ml组与1.2 ml组、1.5ml组差异均有统计学意义(P<0.05);曲线上升支斜率、曲线上升支下面积在4组间差异无统计学意义(P>0.05)。结论一定范围内造影剂量对时间-强度曲线参数影响不显著,但增至2.4 ml时差异较显著。 Objective To analyze the effect on time-intensity curve( TIC) parameters with different doses of ultrasound contrast agent in renal malignant tumors. Methods Thirty-one cases of renal cancer patients were administrated with Sono Vue at four dosage groups( 1. 2 ml,1. 5 ml,2. 0 ml,2. 4 ml) respectively. Contrast-enhanced ultrasound was performed before operation. Enhancement images were analyzed quantitatively by TIC and the parameters of four groups such as arrival time,time to peak,peak intensity,ascending slope rate,and area under ascending curve were acquired and analyzed. Results The arrival time and the time to peak were decreased along with the dosage in four groups and significant differences( P〈0. 05) were observed between 2. 4 ml groups and other dosage groups. The peak intensity was increased along with the dosage in four groups and significant differences were found between 2. 4 ml group and 1. 2 ml group,1. 5 ml group( P〈0. 05). There were no significant differences in four groups on the ascending slope rate and the area under ascending curve( P〈0. 05). Conclusion There is no significant differences on TIC with a certain range of dosage on CEUS for evaluating renal tumors,but increased to 2. 4 ml dose may cause significant differences.
出处 《临床军医杂志》 CAS 2016年第6期620-623,共4页 Clinical Journal of Medical Officers
基金 沈阳市科技基金项目(F15-139-9-30)
关键词 超声造影 剂量 肾恶性肿瘤 时间-强度曲线 Contrast-enhanced ultrasound Doses of contrast agent Renal malignant tumors Time-intensity curve
  • 相关文献

参考文献11

  • 1Nilsson A.Contrast-enhanced ultrasound of kidneys[J].Eur Radiol,2004,14(Suppl 8):104-109.
  • 2徐作峰,万广生,谢晓燕,吕明德,徐辉雄,刘广健,黄蓓.肾细胞癌的超声造影研究[J].中华超声影像学杂志,2008,17(8):694-696. 被引量:1
  • 3董怡,王文平,丁红,范培丽,曹佳颖,林希元.实时谐波超声造影技术定量评价正常人肾脏皮质灌注[J].中国医学计算机成像杂志,2008,14(2):160-164. 被引量:16
  • 4王秀云,杨秀华,宁晓明,石清涛,张守信.肾肿瘤血管的实验研究[J].中国医学影像技术,2008,24(6):840-842. 被引量:7
  • 5Kevin W,Elizabeth L,Jian PB,et al.Quantification of renal blood flow with Contrast-enhanced ultrasound[J].J Am coll cardiol,2001,37:1135-1140.
  • 6George AT,Carol EB,Brent HA,et al.Renal cortical ischemia in rabbits revealed by contrast-enhanced power Doppler sonography[J].AJR,1998,170(2):417-422.
  • 7Madjar H,Prompeler HJ,Favero CD,et al.A new Doppler signal enhancing agent for flow assessment in breast lesions[J].Eur J Ultrasound,2000,12(2):123-130.
  • 8Gabriela SS,Lisa SZ,Susan S,et al.Dose-response relationship of ultrasound contrast agent in an in vivo murine melanoma model[J].Cancer Imaging,2007,7:216-223.
  • 9Maruyama H,Matsutani S,Saisho H,et al.Grey-scale contrast enhancement in rabbit liver with DMP115 at different acoustic power levels[J].Ultrasound Med Biol,2000,26(9):1429-1438.
  • 10李杰,董宝玮,于晓玲,王兴华.肝灰阶超声造影剂量与效果关系的实验研究[J].中华超声影像学杂志,2004,13(7):547-550. 被引量:23

二级参考文献30

  • 1张倜,孙惠川,汤钊猷.肿瘤血管异质性及其研究意义[J].国外医学(肿瘤学分册),2005,32(2):94-97. 被引量:4
  • 2马艳,龚渭冰,侯连兵,马俊杰.移植肾急性排斥血流灌注与生化指标变化关系的实验研究[J].中国超声医学杂志,2005,21(7):490-493. 被引量:10
  • 3杨斌,傅宁华,沈德娟,孟庆欣,段晓艳,刘萍.肾肿瘤的超声造影研究[J].中华超声影像学杂志,2007,16(7):599-601. 被引量:48
  • 4Thorelius L. Contrast-enhanced ultrasound for extrahepatic lesions: preliminary experience. Eur J Radiol,2004,51 :S31-38.
  • 5Nilsson A, Contrast-enhanced ultrasound of kidneys. Eur Radiol, 2004,14(Suppl 8) :104-109.
  • 6Ascenti G, Gaeta M, Magno C, et al. Contrast enhanced second harmonic sonography in the detection of pseudocapsule in renal cell carcinoma. Am J Roentgenol, 2004,182 : 1525-1530.
  • 7Tamai H, Takiguchi Y, Oka M, et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med, 2005,24: 1635-1640.
  • 8Park BK,Kim B, Kim SH, et al. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrastenhanced US. Eur J Radiol,2007,61:310-314.
  • 9Lee E, Angerson WJ, Yarmenitis S, et al. Multi-center clinical study evaluating the efficacy of SonoVueTM (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol, 2002,41 : 200-206.
  • 10Maruyama H, Matsutani S, Saisho H, et al. Gray-scale contrast enhancement in rabbit liver with DMP115 at different acoustic power levels. Ultrasound Med Biol, 2000,26:1429-1438.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部